申请人:Hadd Michael J.
公开号:US20130225614A1
公开(公告)日:2013-08-29
Provided herein are 4-azolylaminoquinazoline compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
本文提供了4-azolylaminoquinazoline化合物,用于治疗JAK激酶介导的疾病,包括JAK2激酶、JAK3激酶或TYK2激酶介导的疾病。还提供了包含这些化合物的制药组合物和使用这些化合物和组合物的方法。